Non-parametric algorithms for evaluating gene expression in cancer using DNA microarray technology
Federated Biological Sciences Department of NJIT and Rutgers-Newark
Doctor of Philosophy
Tolias, Peter P.
Schwalb, Marvin N.
Hart, Ronald Philip
Microarray technology has transformed the field of cancer biology by enabling the simultaneous evaluation of tens of thousands mRNA expression levels in a single experiment. This technology has been applied to medical science in order to find gene expression markers that cluster diseased and normal tissues, genes affected by treatments, and gene network interactions. All methods of microarray data analysis can be summarized as a study of differential gene expression. This study addresses three questions, 1) the roles of selectively expressed genes for the classification of cancer, 2) issues of accounting for both experimental and biological noise, and 3) issues of comparing data derived from different research groups using the Affymetrix GeneChipTM platform. A key finding of this study is that selectively expressed genes are very powerful when used for disease classification. A model was designed to reduce noise and eliminate false positives from true results. With this approach, data from different research groups can be integrated to increase information and enable a better understanding of cancer.
njit-etd2004-077 (147 pages ~ 11,039 KB pdf)
Please complete this Feedback Form to inform us about your experience using this website. It will assist us in better serving your information needs in the future. Thank You!
Created December 23, 2004